PATENT CLAIM ANALYSIS

Application Number: 16137028
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["424", "093200"]

Abstract:
The disclosure relates to compositions and methods for the preparation, manufacture and therapeutic use of polynucleotides encoding AADC for the treatment of Parkinson's Disease.

Claim (Index 8):
The AAV vector genome of  claim 7 , wherein the CMV sequence region comprises a nucleotide sequence consisting of nucleotides 263 to 769 of SEQ ID NO 6.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 97.0
- Lexical Diversity: 1.17391
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15524986', '14242648', '15191357', '13400945', '15894538']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6869380063519704
- 35 USC 102 Novelty (BERT): 0.5487094738096292
- Combined Prediction Score: 0.6731151530977363
- Mean Citation Score: 261.752972
- Max Citation Score: 398.06946
- Similarity Product: 297.8733902075422

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test